Small Midcap Mantra: This pharma stock is poised for a 25-40% rebound after a sharp fall
Wockhardt has more than doubled investor wealth in the past year but has been an underperformer so far in 2021, up 2 percent compared with an over 12 percent rally in the Nifty 50 and the Nifty Pharma index.
The stock hit a 52-week high of Rs 804.50 on…
